Sabe, H., Inoue, A., Nagata, S., Imura, Y., Wakamatsu, T., Takenaka, S., & Tamiya, H. (2021). Tocilizumab Controls Paraneoplastic Inflammatory Syndrome but Does Not Suppress Tumor Growth of Angiomatoid Fibrous Histiocytoma. Case Rep Oncol Med.

Sabe, Hideaki, Akitomo Inoue, Shigenori Nagata, Yoshinori Imura, Toru Wakamatsu, Satoshi Takenaka, and Hironari Tamiya. "Tocilizumab Controls Paraneoplastic Inflammatory Syndrome but Does Not Suppress Tumor Growth of Angiomatoid Fibrous Histiocytoma." Case Rep Oncol Med 2021.

Sabe, Hideaki, et al. "Tocilizumab Controls Paraneoplastic Inflammatory Syndrome but Does Not Suppress Tumor Growth of Angiomatoid Fibrous Histiocytoma." Case Rep Oncol Med 2021.